A mixture, not a molecule
Thymalin is a preparation derived from thymus tissue containing multiple peptide components. It is not one sequence with one molecular weight, and that is a categorical difference from almost everything else in this catalogue.
The practical consequence is immediate. When you analyse a defined peptide you confirm one identity and one purity figure. When you analyse an extract you are characterising a profile, and two batches that both pass can still differ.
The accurate reply to what is thymalin is not a molecule but a mixture: a thymic preparation of several peptide components rather than one defined sequence. That single fact reshapes everything downstream, from what analysis can establish to whether two batches are the same.
What a certificate can say here
For a single sequence, HPLC gives you a purity percentage that means something specific: this proportion of the material is the named compound. For a multi-component preparation that framing does not apply in the same way.
We would rather explain that than print a number that implies more precision than the material allows. If batch-to-batch consistency is critical to your work, a defined sequence is the better choice and we will say so.
This is also where a certificate becomes easy to misread. A document quoting a crisp purity percentage for a multi-component preparation is claiming a precision the material cannot carry, and telling the difference is a large part of what spotting a weak or fabricated COA comes down to.
| Type | Thymic extract, multiple components |
| Not | A single defined sequence |
| Origin | Thymus tissue |
| Research focus | Immune function and ageing |
| Format | Pre-filled peptide pen |
| Analysis | Profile rather than single-compound purity |
| Evidence base | Largely older Russian-language work |
| Category | Research use only |
What the vial contains and how it behaves. Not what it achieves.
Where the research comes from
Thymalin comes out of the same Russian research tradition as several other compounds here, and the work concentrates on immune function in ageing. Much of it is decades old and published in a limited set of journals.
The same two filters apply as elsewhere: which model produced a finding, and has anyone outside the original group repeated it. Applied here, they leave a modest amount standing.
Much of that older, largely Russian-language work is reachable through the record on PubMed, and searching it is instructive for a second reason: a preparation of this kind can be written about under more than one name, so the literature is harder to assemble than for a single defined compound. Where thymalin sits among the other ageing-related compounds is mapped on the energy and longevity area.
When a defined sequence is the better tool
If batch-to-batch consistency is central to your work, an extract is the harder starting point, because two lots that both pass can still differ in composition. A defined peptide removes that variable, and the quality standard can then say something exact about it that it cannot say here.
None of that is a verdict on thymalin itself. It is a statement about what kind of material it is and what a laboratory can and cannot certify about a mixture. Read that way the two are not really competitors: they answer different questions, and only one of them can be pinned to a single line on a certificate.
Thymalin in the catalogue
Released only once HPLC confirms 99% or better, documented per lot.
Where Thymalin fits in
Related material, for readers who want the wider frame.
About Thymalin
What people write in to ask about this material.